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Atherosclerotic plaque rupture in 
symptomatic arotid artery stenosis 
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and James S. T. Yao, MD,  Phi) ,  Chicago, Ill., and Washington, D.C. 
Purpose: Plaque rupture is often the precipitating event in acute coronary syndromes. We 
hypothesized that a similar process occurs in stenotic arotid plaques in association with 
ischemic neurologic symptoms. Our purpose was to examine several morphologic features 
of stenotic arotid plaques and to determine which characteristics are more commonly 
associated with plaques obtained from patients with symptomatic carotid artery disease 
than with those from patients with asymptomatic carotid artery disease. 
Methods: Forty-four carotid endarterectomy specimens (from 25 asymptomatic and 19 
symptomatic patients) were analyzed with pentachrome staining and light microscopy. The 
asymptomatic patients and symptomatic patients had similar mean percent stenosis (77% 
vs 74%). Other risk factors, including hypertension, diabetes mellitus, coronary artery 
disease, smoking history, serum cholesterol, and triglyceride l vels, were similar between 
groups. 
Results: Patients with symptomatic carotid artery disease were found to have more frequent 
plaque rupture, fibrous cap thinning, and fibrous cap foam-cell infiltration when compared 
with the asymptomatic group. Plaque rupture was seen in 74% of symptomatic plaques and 
in only 32% of plaques from asymptomatic patients (p = 0.004). Fibrous cap thinning was 
noted in 95% of symptomatic plaques and in 48% of asymptomatic plaques (p = 0.003). 
Infiltration of the fibrous cap with foam cells was also significantly more common in the 
symptomatic plaques (84% vs 44% of asymptomatic plaques; p = 0.006). In addition, 
intraplaque fibrin was more common in symptomatic plaques than in asymptomatic (100% 
vs 68%; p = 0.008). No significant differences were found between the two groups with 
respect to plaque hemorrhage, the presence of a necrotic ore, luminal thrombus, smooth 
muscle cell infiltration, eccentric shape, and plaque type (fibrous, necrotic, or calcified). 
Conclusions: As in the coronary artery system, rupture of the atherosclerotic plaque may 
play an important role in the pathogenesis of ischemic stroke caused by carotid artery 
stenosis. The process of inflammation, involving foam-cell infiltration of the fibrous cap, 
may contribute to rupture of the atherosclerotic plaque. (J Vasc Surg 1996;23:755-66.) 
Recent clinical studies demonstrate he benefit of  
carotid endarterectomy in patients with symptomatic 
or asymptomatic carotid artery disease. 1-s In patients 
who have significant carotid artery stenosis, those 
treated medically have a significantly greater isk of 
stroke and transient ischemic attack than those treated 
surgically. For example, patients with asymptomatic 
carotid artery disease who have significant stenosis 
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progress to have ipsilateral neurologic extents (amau- 
rosis fugax, transient ischemic attack, or stroke) at a 
rate of 20.6% over 47.9 months, and progress to a 
clinically detectable cerebral infarction at a rate of 
11% over 2.7 years. 4,S In addition, in a careful natural 
history study, Roederer et al.6 studied asymptomatic 
patients who did not undergo surgery and found that 
plaque progression (degree of stenosis) was com- 
mon, occurring in 60% of patients. Rapid progres- 
sion of carotid stenosis from relatively minor degrees 
to high-grade stenosis and symptoms occurred in 8%. 
In three patients, progression from <50% stenosis to 
total occlusion occurred in 12 to 36 months. Pro- 
gressive occlusive disease was associated with smok- 
ing history, the presence of diabetes mellitus, and an 
age of less than 65 years. Thus the onset of neu- 
rologic symptoms appears to occur with plaque 
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progression, particularly when the stenosis exceeds 
80%. 
The biologic events that lead to carotid plaque 
progression with the production of ischemic events 
have been the focus of many basic investigations. A 
variety of plaque characteristics have been associated 
with the onset of symptoms. Imparato ct al.,7 Persson 
et al., s Avril et al.,9 and Bornstein et al.10 described 
intraplaque hemorrhage asan important process asso- 
ciated with carotid plaque progression and the devel- 
opment of neurologic symptoms. Van Damme and 
colleagues, ha2 however, found that the only signifi- 
cant clinicopathologic correlation was the presence of 
fresh thrombus exposed to the vessel lumen. The role 
of other variables, including the presence or absence 
of ulceration, plaque size, and degree of stenosis, in 
the production of neurologic symptoms is uncer- 
tain. 1°'n'13-15 In the coronary circulation, changes in 
plaque morphologic features also appear to play a key 
role, and many correlations may bc drawn with the 
carotid plaque. Plaque disruptions are found beneath 
approximately 75% of the thrombi responsible for 
acute coronary syndromes. 16qs Coronary plaque dis- 
ruption is thought o be related to the intrinsic prop- 
erties of the plaques and to extrinsic forces. Several 
intrinsic factors may influence plaque stability. The 
progressive accumulation of lipids may lead to thin- 
ning and weakening of the fibrous cap.18 In addition, 
disrupted fibrous caps arc infiltrated by macrophage 
foam cells. 19 These foam cells are activated, which in- 
dicates ongoing inflammation at the site of plaque 
disruption. 19 The purpose of this study was to analyze 
plaque morphologic features in patients who under- 
went carotid endarterectomy for asymptomatic or 
symptomatic disease. Because asymptomatic carotid 
plaques frequently progress to produce symptoms, 
the study of patients with asymptomatic carotid artery 
plaques may shed light on precursor plaque changes 
that may eventually produce symptoms. 
MATERIALS AND METHODS 
Patients. Forty-four patients who underwent ca- 
rotid endarterectomy at Northwestern Memorial 
Hospital and Veterans Affairs Lakeside Medical Cen- 
ter were studied prospectively. Indications for surgery 
included symptomatic carotid artery stenosis or high- 
grade asymptomatic stenosis (>70%). The patients 
were enrolled according to an approved Institutional 
Review Board protocol, and all patients gave in- 
formed consent. Thirty-three patients were men and 
11 were wofnen, with a mean age of 74 years for 
asymptomatic patients and 70 years for symptomatic 
patients. 
Patients' medical records were reviewed, and risk 
factors were recorded. These factors included age, 
sex, hypertension, diabetes mellitus, coronary artery 
disease, past and present smoldng status, and serum 
total cholesterol and triglyceride levels. Patients' 
symptoms and the time of the most recent symptom 
before surgery were documented. Patients were con- 
sidered symptomatic if they had experienced stroke, 
transient ischemic attack, or amaurosis fugax ipsilat- 
eral to the carotid lesion being studied. Twenty-five 
asymptomatic patients and 19 symptomatic patients 
were studied. The symptomatic group had signifi- 
cantly more men (p = 0.01 ). Other risk factors, how- 
ever, were not significantly different between the two 
groups (Table I). Of the symptomatic patients, 11 had 
transient ischemic attacks and eight had amaurosis 
fugax ipsilateral to the stenotic lesion. None of the 
symptomatic patients in this study had previous troke 
ipsilateral to the lesion being studied. 
Preoperative evaluation. M1 patients underwent 
preoperative duplex scan of the carotid arteries. Ca- 
rotid angiography was performed in 39 patients 
(89%). The percent stenosis was calculated according 
to the criteria from the North American Symptomatic 
Carotid Endarterectomy Trial. The percent stenosis 
for each group was not significantly different: 
77% + 15% for asymptomatic lesions and 74% + 17% 
for symptomatic lesions (p = 0.57). Five patients did 
not have angiograms taken but underwent magnetic 
resonance angiography. The number of patients in 
each duplex category was not significantly different 
between symptomatic and asymptomatic patients 
(p = 0.46; Table II). 
Histology. Carotid endarterectomy was per- 
formed in each patient with standard surgical tech- 
niques with minimal manipulation of the specimen. 
During surgery the presence of gross ulceration and 
plaque hemorrhage was noted and recorded by the 
attending surgeon with the plaque remaining in situ. 
Gross ulceration was defined as plaque surface irregu- 
larity seen by the surgeon at the time of arteriotomy. 
Plaque hemorrhage was noted grossly by looking for 
evidence of blood within the plaque. The plaques 
were removed en bloc and fixed in 10% buffered for- 
malin. The specimens were decalcified overnight, 
transected transversely at 3 to 4 ram, and embedded in 
paraffin. After staining with hematoxylin and eosin 
and movat pentachrome stain, a total of three to four 
sections per specimen were examined. The section 
with plaque ulceration or thrombus, the most stenotic 
segment of the plaques, or both sections were chosen 
for further analysis. Sections were evaluated by a pa- 
thologist (R.V.), who was blinded to the clinical find- 
ings and identity of each patient. Movat pentachrome 
stain is a connective tissue stain that stains elastin 
black, collagen yellow, and proteoglycans green. 
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Table I. Risk factors 
Asymptomatic (n = 25) Symptomatic (n = 19) p 
Age 73 + 6 yr 70 _+ 8 yr 0.17 
Total cholesterol 219 + 57 mg/dl  201 _+ 65 mg/dl  0.42 
Triglycerides 211 +_ 178 mg/dI 162 + 78 mg/dl  0.38 
Male sex 16 (64%) 17 (89%) 0.01 
Hypertension 16 (64%) 11 (58%) 0.68 
Diabetes mellitus 4 (16%) 3 (16%) 0.95 
Coronary artery disease 13 (52%) 14 (74%) 0.15 
Smoking 18 (72%) 16 (84%) 0.39 
Table II. Angiographic and duplex categories 
Duplex categories 
% Stenosis on 
angiogram Normal <60% 60% to 79% 80% to 99% Occluded 
Asymptomatic 77% + 15% 0 2 9 14 0 
Symptomatic 74% + 17% 0 4 6 9 0 
Totals 0 6 15 23 0 
Table II I .  Gross morphology 
Asymptomatic Symptomatic 
(n =25) (n =17) p 
Gross ulceration 16 (64%) 16 (94%) 0.02 
Plaque hemorrhage 13 (52%) 8 (47%) 0.75 
Table IV. Microscopic plaque characteristics 
Asymptomatic Symptomatic 
(n = 25) (n = 19) p 
Plaque rupture 8 (32%) 14 (74%) 0.004 
Fibrous cap thinning 12 (48%) 18 (95%) 0.003 
Cap foam cells 11 (44%) 16 (84%) 0.006 
Intraplaque fibrin 17 (68%) 19 (100%) 0.008 
Intraplaque hemorrhage 14 (56%) 16 (84%) 0.06 
Necrotic core 18 (72%) 16 (84%) 0.38 
Ulceration 2 (8%) 2 (11%) 0.74 
Tbrombus 20 (80%) 12 (63%) 0.19 
Smooth muscle cell rich 0 (0%) 1 (5%) 0.24 
Eccentric shape 16 (64%) 13 (68%) 0.83 
Each plaque was evaluated for the presence of a 
necrotic ore, amount of calcification, microscopic ul- 
ceration, plaque rupture, intraplaque hemorrhage, 
thrombus, infiltration with smooth muscle cells, ec- 
centric versus concentric shape, fibrous cap thinning, 
infiltration of the fibrous cap with foam cells, and in- 
traplaque fibrin. Plaques were also classified as fibrous, 
necrotic, or calcific, depending on which of these 
components predominated. Microscopic ulceration 
was defined by a defect in the endothelium with over- 
lying thrombus. The artifact of surgical cutting was 
identified by direct communication f the tract from 
the periphery to the lumen or within the plaque. 
Plaque rupture was associated with a thin fibrous cap 
unrelated to the surgical tract. Intraplaque hemor- 
rhage was defined as the presence of blood and 
thrombus within the plaque when seen microscopi- 
cally. Hemorrhage was used to refer to a hematoma 
within the carotid plaque that contained all of the 
blood elements. Thrombus was defined by the pres- 
ence of platelets or fibrin, characterized by lamina- 
tion with or without red and white cells interspersed, 
or both. 
Statistical analysis, t Tests for continuous vari- 
ables and ~2 tests for categoric variables were used for 
testing statistical significance. Because multiple tests 
were performed, a significance l vel o fp  < 0.01 was 
used to correct for alpha inflation. 
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Hg. 1. A, Low-power view of Movat's pentachrome stain of moderately stenotic, concentric 
plaque with rupture of fibrous cap (arrow). B, Higher-power view of fibrous cap adjacent to 
rupture site containing foam cells. 
RESULTS 
Information about the gross appearance of the 
plaque in situ at the time of carotid endarterectomy 
was recorded for 25 asymptomatic plaques and 17 
symptomatic plaques. As shown in Table III, the 
incidence of gross ulceration was significantly more 
common in the symptomatic plaques than in plaques 
from asymptomatic patients. Gross ulceration was 
noted in 94% of symptomatic plaques and in 64% of 
asymptomatic plaques (p = 0.02). Gross plaque hem- 
orrhage seen in the operating room was noted in 47% 
of symptomatic plaques and in 52% of asymptomatic 
plaques (p = NS). 
Table IV lists the morphologic features tudied 
microscopically and the frequency that each charac- 
teristic was present in the asymptomatic and symp- 
tomatic groups. Of all morphologic features that were 
examined, only four were found to be significantly 
more common in symptomatic plaques than in 
asymptomatic plaques (p < 0.01). These four charac- 
teristics were plaque rupture, fibrous cap thinning, 
infiltration of the cap with foam cells, and intraplaque 
fibrin. Plaque rupture was found in 74% of symptom- 
atic plaques and in only 32% ofasymptomatic plaques 
(p = 0.004; odds ratio = 3.2). As shown in Fig. 1, A, 
most plaque ruptures that were identified occurred at 
JOURNAL OF VASCULAR SURGERY 
Volume 23, Number 5 Carr  et al. 759 
the midportion of the plaque rather than at the 
shoulder area. Thinning of the fibrous cap was ob- 
served in 95% of symptomatic plaques and in 48% of 
asymptomatic plaques (p = 0.003; Fig. 2). Infiltration 
of the fibrous cap with foam cells was seen in 84% of 
symptomatic plaques and in only 44% of asymptom- 
atic plaques (p = 0.006; Fig. 3). Intraplaque fibrin was 
observed in all symptomatic plaques and in 68% of 
asymptomatic plaques (p = 0.008). Fig. 4 shows an 
example of intraplaque fibrin found within the lipid 
core of a plaque. Plaque rupture, fibrous cap thinning, 
and infiltration of the cap with foam cells were 
significantly correlated with each other. If all three of 
these features were present within a plaque, there was 
a 77% chance that the plaque would be from a 
symptomatic patient. 
The incidence of intraplaque hemorrhage de- 
tected microscopically was also higher in the plaques 
from symptomatic patients (84% vs 56% ofasymptom- 
atic patients), but the difference was of borderline sig- 
nificance (p= 0.06). Intraplaque hemorrhage did, 
however, correlate strongly with plaque rupture. 
Ninety-five percent of plaques with rupture were also 
found to have associated intraplaque hemorrhage 
(p= 0.0001). Intraplaque hemorrhage also corre- 
lated strongly with intraplaque fibrin; 8 i% of plaques 
that contained fibrin also had intraplaque hemorrhage 
(p < 0.0001). Risk factors, including age, hyperten- 
sion, diabetes mellitus, smoking history, coronary ar- 
tery disease, and cholesterol and triglyceride l vels did 
not correlate significantly with plaque rupture. The 
type of plaque present (fibrous, necrotic, or c~ilcific) 
was not found to be a significant factor in predicting 
the presence of symptoms (p = 0.18; Table V). 
As shown in Table VI, the data then were further 
analyzed by dividing the group of symptomatic pa- 
tients into those who had had symptoms within 2 
weeks before surgery (n = 9) and those who had more 
remote symptoms greater than 2 weeks before surgery 
(n = 10). Interestingly, the incidence of thrombus 
overlying the plaque was much less common in pa- 
tients who had had symptoms within 2 weeks before 
surgery (33 %) when compared with the asymptomatic 
patients (80%) and with patients with more remote 
symptoms greater than 2 weeks before surgery (90%; 
p = 0.02; Fig. 5). Again, plaque rupture, fibrous cap 
thinning, infiltration of the cap with foam cells, and 
intraplaque fibrin were significantly more common in 
both symptomatic groups when compared with the 
asymptomatic group (p < 0.05), with no significant 
difference between the two symptomatic groups. 
DISCUSSION 
Rupture of the plaque fibrous cap with thrombosis 
occurs frequently during the evolution of atheroscle- 
rotic lesions and is probably the most important single 
mechanism underlying sudden and rapid plaque pro- 
gression. The fibrous cap, which contains elastin, 
collagen, and proteoglycans, covers the necrotic ore 
and separates this collection of cellular debris and 
cholesterol c efts from the arterial lumen. Disruption 
of this fibrous cap (plaque rupture) allows the throm- 
bogenic lipid core to communicate with the arterial 
lumen. Thinning of the fibrous cap and infiltration of 
the cap with foam cells are commonly seen in areas 
adjacent o plaque rupture. Overlying thrombus is 
seen frequently in areas of plaque rupture. 17,~8 In our 
study four morphologic features were identified more 
commonly in symptomatic patients: plaque rupture, 
fibrous cap thinning, infiltration of the fibrous cap 
with foam cells, and intraplaque fibrin. The incidence 
ofintraplaque hemorrhage also appeared to be higher 
in plaques from symptomatic patients, but the differ- 
ence was not statistically significant ( p = 0.06). When 
these data were analyzed by separating the group of 
symptomatic patients into those who had had symp- 
toms within 2 weeks and those who had more remote 
symptoms, the incidence of thrombus overlying the 
plaque was significantly less in the patients who had 
recent symptoms (<2 weeks). 
Similar histologic hanges arc seen in acute coro- 
nary syndromes. Intrinsic factors that contribute to 
thinning of the fibrous cap include the loss of collagen 
and the infiltration of inflammatory cells. Data from 
this study suggest that a process imilar to that that 
occurs in acute coronary syndromes may contribute 
to the pathogenesis of ischemic neurologic symp- 
toms. The processes that are responsible for plaque 
rupture in carotid artery disease are as yet unknown. 
In aortic plaques enlargement ofthe lipid core within 
the plaque is thought o erode the fibrous cap, which 
leads to release of the thrombogenic lipid debris. 2° 
Alternatively, the process ofintraplaque hemorrhage 
may play a role in the thinning, weakening, and 
rupture of the fibrous cap. Further studies are needed 
to examine which factors are responsible for plaque 
rupture. 
Immune mechanisms have been implicated in the 
pathogenesis ofatherosclerosis and may contribute to 
fibrous cap thinning and rupture. 21-23 In our study, 
the proportion of plaques that had infiltration of the 
fibrous cap with foam cells was significantly higher in 
the symptomatic plaques than in those from the 
asymptomatic group. Immunohistochemical studies 
of coronary artery plaques have demonstrated an 
abundance of foamy macrophages and, to a lesser 
extent, T lymphocytes at the site of fibrous cap 
rupture and thinning. Inflammatory cells adjacent to 
areas of plaque rupture are characterized by abundant 
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Fig. 2. A, Low-power view of Movat's pentachrome stain of moderately stenotic, eccentric 
plaque with thinning of fibrous cap (arrow) and plaque rupture. B, High-power view demon- 
strates thinning of fibrous cap adjacent to area of rupture. L, Lumen of artery; N, necrotic ore. 
Table V. Plaque type 
Asymptomatic Symptomatic 
(n ~ 25) (n ~ 19) 
Fibrous 8 (32%) 2 (11%) 
Necrotic 14 (56%) 16 (84%) 
Calcific 3 (12%) 1 (5%) 
expression of HLA-DR antigens, which suggests an 
active inflammatory eaction.~9 Plaque rupture in the 
coronary system has been reported to occur at the 
shoulder area of  the plaque, which is the area that is 
most heavily infiltrated with foam cells) 7'1s In our 
study plaque rupture was not found at the shoulder 
area of the plaque, but rather at tile midportion. This 
area, however, was also infiltrated with numerous 
foam cells. Farb et al.24 noted a higher incidence of 
coronary plaque rupture in the center of the fibrous 
cap rather than in the shoulder egions in coronary 
arteries. Bassiouny et al. 13 also noted a chronic inflam- 
matory response near the surface of  many of the com- 
plex carotid lesions, including foam-cell accumulation 
in areas of fibrous cap thinning. Macrophages within 
carotid plaques produce cytokines and matrix metal- 
loproteinases that may directly degrade the fibrous 
cap. Alternatively, the fibrous cap may be degraded 
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Fig. 3. High-power view ofthin fibrous cap adjacent to rupture site containing foam cells. L, 
Lumen of artery; N, necrotic core. 
Table VI. Microscopic plaque characteristics 
Asymptomatic Symptoms ~2 wk Symptoms >2 wk 
(n =25) (n =9) (n =10) p 
Thrombus 20 (80%) 3 (33%) 9 (90%) 0.02 
Plaque rupture 8 (32%) 7 (78%) 7 (70%) 0.03 
Fibrous cap thinning 12 (48%) 9 (100%) 9 (90%) 0.02 
Cap foam cells 11 (44%) 8 (89%) 9 (90%) 0.03 
Intraplaque fibrin 17 (68%) 9 (100%) 10 (i00%) 0.02 
Hemorrhage 14 (56%) 7 (78%) 9 (90%) 0.12 
Necrotic core 18 (72%) 7 (78%) 9 (90%) 0.52 
Ulceration 2 (8%) 1 (11%) 1 (10%) 0.09 
SMC rich 0 (0%) 0 (0%) 1 (10%) 0.12 
Eccentric shape 16 (64%) 7 (78%) 6 (60%) 0.68 
SMC, Smooth muscle cell. 
indirectly by the juxtacrine function of cytokines and 
growth factors. 23'25'26 Finally, alterations in hemody- 
namic forces, such as increasing blood pressure and 
shear stress, may contribute to cap fatigue and eventu- 
ally rupture. 27 More studies are needed to better elu- 
cidate the role of macrophages and other inflamma- 
tory cells in carotid plaque disruption. 
Fibrin is a common finding in mature atheroscle- 
rotic lesions. Intraplaque fibrin most likely represents 
chronic hemorrhage within the plaque. Intraplaque 
hemorrhage is a morphologic haracteristic that has 
been studied extensively in the carotid artery. Several 
studies have correlated the presence of intraplaque 
hemorrhage with symptomatic carotid artery steno- 
sis, suggesting that hemorrhage within the plaque 
may lead to critical stenosis or to disruption of the 
plaque and release ofmicroembolic material.7-1° Stud- 
ies that examined the importance of intraplaque 
hemorrhage in carotid artery disease have had con- 
flicting results. Several authors have demonstrated an
increased incidence of intraplaque hemorrhage in 
plaques taken from symptomatic patients. 7-a° Other 
investigators, however, have concluded that there is 
no significant difference in the proportion of plaques 
with intraplaque hemorrhage between symptomatic 
and asymptomatic groups of carotid plaques. 1~14 In 
our study, the proportion of plaques that were 
thought to have intraplaque hemorrhage by gross 
examination was very similar between symptomatic 
and asymptomatic patients (47% and 52%, respec- 
tively). Microscopic examination, which is more ac- 
curate for detecting the presence of hemorrhage 
within the plaque, revealed an increased incidence of 
intraplaque hemorrhage in symptomatic plaques 
when compared with asymptomatic plaques (84% and 
56%, respectively). Although the incidence of intra- 
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Hg. 4. High-power view of fibrin within plaque lipid core. L, Lumen of artery. 
plaque hemorrhage seen microscopically was not 
significantly different between the two groups in this 
study, a trend was seen. That the presence of intra- 
plaque hemorrhage correlated significantly with the 
presence of plaque rupture suggests hat hemorrhage 
into the plaque may be one of the factors that 
predispose to rupture of the fibrous cap. 
Although arterial occlusion occurs with carotid 
artery disease, many patients' neurologic symptoms 
are caused by emboli arising from a stenotic lesion 
rather than thrombotic occlusion of the artery. In our 
study all patients in the group with neurologic signs 
within 2 weeks of surgery had a recent transient 
ischemic attack or amaurosis fugax. Studies of carotid 
plaque specimens performed byVan Damme t al. TM 
have emphasized the importance of fresh thrombus 
exposed to the bloodstream in the pathophysiology f 
ischemic neurologic symptoms. They found fresh 
thrombus in 80% of the plaques from patients who 
had previous transient ischemic attack and in 80% of 
patients who had amaurosis fugax. Harrison and 
Marshall 28 also suggested that thrombus may be 
important in producing neurologic symptoms in 
patients with carotid artery disease. They found, 
however, friable thrombus in 66% of plaques from 
patients who underwent surgery within 4 weeks of a 
transient ischemic attack, but in only 21% of patients 
in whom the time interval was longer. Our data, on 
the other hand, showed that thrombus i commonly 
absent in plaques from patients with recent symp- 
toms. These data suggest that thrombus formation is
intermittent. Studies of carotid endarterectomy speci- 
mens represent a  instantaneous view of what is likely 
a dynamic process of rupture, thrombus formation, 
healing, and remodeling of the plaque. It is possible 
that loss of this thrombus from the plaque surface is 
associated with the neurologic symptoms that are seen 
clinically. All symptomatic patients in our study had 
amaurosis fugax or transient ischemic attack associ- 
ated with significant stenosis, rather than a recent 
stroke, as an indication for surgery. The pathogenic 
role that thrombus formation plays in ischemic neu- 
rologic symptoms may be different between patients 
with transient events and those with permanent 
neurologic deficits. 
The importance of ulceration as a morphologic 
feature of carotid plaques ignificantly associated with
hemispheric neurologic symptoms varies greatly be- 
tween studies. This variation may be partly explained 
by differences in the definitions of ulceration that are 
used. In our study gross ulceration was defined as 
plaque surface irregularity identified at the time of 
surgery. Gross ulceration occurred in 94% of symp- 
tomatic plaques and in 64% of asymptomatic plaques 
(p = 0.02). The data from this small patient popula- 
tion support the conclusion that ulceration does 
correlate significantly with ipsilateral ischemic neuro- 
logic symptoms. These findings are consistent with 
earlier studies by Avril et al. 9 and Sterpetti et al. 14 In 
contrast to gross ulceration, the definitions of micro- 
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Hg. 5. A, Low-power view of severely stenotic, eccentric, necrotic plaque with rupture (arrow) 
and plaque hemorrhage. B, High-power view of fibr n thrombus at site of rupture. L, Lumen of 
artery. 
scopic ulceration tend to be more variable. Many 
pathologists define microscopic ulceration as plaque 
rupture with thrombus or as intimal erosion and 
overlying thrombus without plaque rupture. In our 
study, plaques with evidence of rupture were classified 
separately from those with intimal disruption (or 
erosion) without rupture. Thus few plaques were 
identified with microscopic ulceration, and no signifi- 
cant difference was found between symptomatic and 
asymptomatic plaques. Other studies that examined 
the importance of microscopic ulceration have had 
varying results. Van Damme t al. 11 noted a significant 
correlation of microscopic ulceration with neurologic 
symptoms, whereas Bassiouny et al. 13 found no sig- 
nificant difference inulceration between symptomatic 
and asymptomatic carotid plaques. Ulceration ap- 
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pears to be closely related to plaque rupture and may 
prove to be an important morphologic feature asso- 
ciated with ipsilateral ischemic neurologic symptoms. 
Studies that look at carotid endarterectomy speci- 
mens examine the late stages of the process of plaque 
evolution. Clearly, symptomatic and asymptomatic 
carotid plaques have more morphologic similarities 
than differences between them. Patients who are 
candidates for carotid endarterectomy usually have a 
severely stenotic lesion that has had many years to 
progress. Early-stage l sions, on the other hand, are 
not removed by carotid endarterectomy and were not 
included in this small data set. The high incidence of 
intraplaque fibrin and plaque hemorrhage in both 
symptomatic and asymptomatic plaques uggests hat 
these are mature atherosclerotic lesions. Examination 
of carotid endarterectomy specimens may give clues 
to the mechanisms of plaque disruption but cannot 
document he process of plaque evolution, which 
likely involves plaque hemorrhage, rupture, ulcer- 
ation, and plaque healing. Evaluation of a carotid 
atherosclerosis specimen in a symptomatic patient 
may not show signs of plaque rupture if the plaque has 
healed or has evolved since the time of neurologic 
symptoms. Furthermore, plaque rupture may not be 
the mechanism of symptom production in every 
patient with symptomatic carotid stenosis, because 
hemodynamic flow changes and other factors likely 
play a role as well. Another limitation of this type of 
study is the process by which patients are classified as 
symptomatic orasymptomatic. Patients were put into 
each category based on history, physical examination, 
computed tomography results, and, sometimes, mag- 
netic resonance imaging findings. For example, pa- 
tients who are unreliable historians or who have had 
silent embolic events that were too small to be 
detected by computed tomography may be classified 
as asymptomatic. 
CONCLUSION 
This preliminary study of carotid plaque morpho- 
logic features demonstrates that plaque rupture, thin- 
ning of the fibrous cap, intraplaque fibrin, and infil- 
tration of the cap with foam cells are associated with 
symptomatic arotid artery stenosis. As in acute 
coronary syndromes, plaque rupture may play a role 
in the pathogenesis ofneurologic symptoms as a result 
of carotid artery disease. Thrombus formation, as in 
coronary artery disease, may also be important in the 
pathogenesis of symptomatic carotid stenosis. Many 
morphologic features were similar between asymp- 
tomatic and symptomatic arotid plaques, which 
indicates that the plaques in both groups consisted of 
mature atherosclerotic lesions. Plaque rupture ap- 
pears to be an event that is associated with the 
progression of a mature asymptomatic plaque to a 
symptomatic lesion. Although plaque rupture, fi- 
brous cap thinning, and infiltration of the cap with 
foam cells are more common in symptomatic patients, 
these findings do not clearly define the role of these 
morphologic hanges in the pathophysiology of ca- 
rotid symptoms. Further studies characterizing the 
inflammatory cell infiltrate within the plaques may 
give more information about he possible role of the 
foam cell, smooth muscle cells, and other plaque 
components in plaque rupture. In addition, studies of 
the molecular changes associated with symptomatic 
plaques may provide valuable information about he 
mechanisms of plaque disruption. 
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DISCUSSION 
Dr. Hisham S. Bassiotmy (Chicago, Ill.). I would like 
to congratulate Dr. Carr and the group from Northwestern 
University Medical Center for this important study. Better 
understanding of the natural history of advanced carotid 
plaques is of major interest o both clinical and basic 
scientists. The reason is obvious. We would like to identify 
the structural features that connote plaque vulnerability to 
mechanical disruptive complications and symptoms. This 
knowledge is invaluable if we are to develop more specific 
diagnostic and treatment algorithms for advanced asymp- 
tomatic arotid disease. 
in this study 44 endarterectomy plaques, 25 of which 
were asymptomatic, were analyzed histopathologically to 
determine the microanatomic features that discriminate 
asymptomatic from symptomatic plaques. Although the 
number of symptomatic plaques is relatively small and the 
study is qualitative, disruption and thinning of the fibrous 
cap, inflammatory cell infiltration, and intraplaque fibrin 
appear more prevalent in symptomatic plaques. These 
exquisitely focal structural findings were noted in the most 
stenotic regions of the plaque. Interestingly, no difference 
was found between symptomatic and asymptomatic plaques 
with regard to other major features that we recognize, such 
as necrosis, thrombosis, hemorrhage, calcification, or 
plaque type. We have previously demonstrated that the 
overall chemical and structural composition i  high-grade 
symptomatic and asymptomatic plaques are similar; testing 
did not distinguish between symptomatic and asymptom- 
atic plaques. :3More specifically, the cellular lipid and matrix 
chemical markers were similar as well as features of plaque 
structures, such as thrombosis, irregularity, tflceration, 
hemorrhage, necrosis, and calcification. 
More recent quantitative analysis of the spacial distri- 
bution of the individual plaque components in 59 symp- 
tomatic and 40 asymptomatic endarterectomized plaques 
revealed that the most distinguishing features were prox- 
imity of the necrotic core to the lumen and fibrous cap 
erosion. In our study only 34% of symptomatic plaques and 
20% ofasymptomatic plaques had complete fibrous cap ero- 
sion with abutting of the necrotic ore to the lumen. Our 
results, therefore, concur with the findings presented here. 
Critical histopathologic analysis ofendarterectomy plaques 
demands precise definition of the different structural com- 
ponents, which leads me to several questions. How did you 
discriminate between mechanical disruption of the plaque 
from operative trauma and actual plaque disruption? You 
define ulceration as lack of endothelial coverage. Was this 
confirmed with antifactor VIII  immunohistochemical 
stains? You suggest that thrombus formation was less com- 
mon in symptomatic plaques; however, you indicate that the 
intraplaque fibrin was more common in thc same plaques. 
What accounts for this discrepancy? Did you cxamine other 
regions of the plaque proximal and distal to the maximum 
region of stenosis, and did they differ from it? In your view, 
what are the underlying events that may trigger plaque ma- 
trix to undergo lysis, fibrous cap thinning, and rupture? 
Clearly, more work is needcd to fur thcr understand the tran- 
sition of asymptomatic plaques to symptomatic plaques o 
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that these findings can be correlated with existing or devel- 
oping imaging methods. This will probably involve better 
sequential quantitative analysis of plaques in relation to 
clinical and biomechanical risk factors. 
Dr. Sandra C. Cart. The first question was about how 
we control for mechanical disruption caused by the opera- 
tion versus actual plaque disruption. In only one or two 
specimens was the plaque cut through at the site of a 
possible plaque rupture, and those specimens were not 
considered as ruptured plaques. In most specimens the area 
of surgical disruption was visible. In the histologic section 
we could see that the area where the plaque was cut was 
different from where the plaque ruptured. It is fairly easy to 
distinguish istologically except for maybe one or two 
specimens. Possibly one or two specimens were not classi- 
fied as ruptured because they were cut through that area. 
The second question was about how we determined the 
presence of ulceration and disruption of the endothelium 
and about staining with immunohistochemistry to factor 
VIII. We did do a immunohistochemical analysis for factor 
VIII. It was rather unreliable in determining the presence of 
the endothelium. I think there is some operative trauma nd 
some trauma with the specimen so that frequently, with the 
use of the factor VIII  stains, a few endothelial cells were 
absent. We did not find the factor VIII  stains to be reliable 
at all. Ulceration was determined by looking at the plaque 
morphologic features microscopically where you could see 
an actual disruption in the plaque. 
The third question was about fibrin being increased in 
the plaque and not hemorrhage. I think the question is a 
very good one. Fibrin is the chronic consequence of 
intraplaque hemorrhage. Hemorrhage into the plaque 
occurs as the plaque matures and as it becomes larger. 
Intraplaque hemorrhage is part of the maturation process of 
a plaque and occurs in most complex carotid plaques. Fibrin 
then accumulates and is found in both symptomatic and 
asymptomatic plaques. You will notice that all of our 
symptomatic plaques did have fibrin because it is part of the 
maturation process. Intraplaque hemorrhage may have 
something to do with starting the inflammatory response 
that occurs in the plaques, and perhaps that is why the 
plaque of symptomatic patients often had more fibrin than 
that of asymptomatic patients. 
The fourth question was about whether we looked at 
other regions of the plaque. Yes, we did. Other regions 
tended to be the beginnings and the ends of the plaque and 
tended to be more fibrous in nature. We concentrated on 
the highly stenotic portion of the plaque, which contained 
most of the morphologic features. 
The last question regarded the underlying events that 
trigger the plaque rupture. Although what event actually 
triggers the plaque rupture is currently unknown, hemody- 
namic factors could be important in disrupting the fibrous 
cap. I think that as more plaques are analyzed, we might find 
that intraplaque hemorrhage is more important and, per- 
haps, that intraplaque hemorrhage may have something to 
do with beginning the inflammatory esponse. I think that 
the inflammatory infiltrate is a very important event that 
may trigger plaque rupture. By producing enzymes and 
other factors that may digest the fibrous cap, leading to 
rupture, this infiltrate of foam cells may prove to be an 
important factor in the pathogenesis ofischemic neurologic 
symptoms that result from carotid artery stenosis. 
Dr. Peter Gloviczki (Rochester, Minn.). My question 
concerns preoperative imaging in these patients. How good 
are our preoperative imaging studies at identifying the 
morphologic features of the plaque? 
Dr. Cart. We performed uplex scans in every patient, 
and we classified the plaques. Basically, we can classify them 
as echogenic or hypoechoic and correlate that with the 
amount of lipid. As Dr. Bassiouny noted in his study, 13 the 
amount of lipid is not different between symptomatic and 
asymptomatic plaques. Our preoperative imaging currently 
is not sensitive nough to detect he changes that occur to 
predict plaque disruption, but that is an area that we are 
currently working on. 
